000			01376 a2200373 4500
005			20250516150657.0
264		0	_c20141218
008			201412s 0 0 eng d
022			_a1467-1107
024	7		_a10.1017/S1047951113000565 _2doi
040			_aNLM _beng _cNLM
100	1		_aTosoni, Alvise
245	0	0	_aThe use of levosimendan in children with cancer with severe acute cardiac dysfunction: case series and a review of the literature. _h[electronic resource]
260			_bCardiology in the young _cJun 2014
300			_a524-7 p. _bdigital
500			_aPublication Type: Case Reports; Journal Article; Review
650	0	4	_aAcute Disease
650	0	4	_aAntineoplastic Agents _xadverse effects
650	0	4	_aCardiotonic Agents _xtherapeutic use
650	0	4	_aChild, Preschool
650	0	4	_aFemale
650	0	4	_aHeart Failure _xchemically induced
650	0	4	_aHumans
650	0	4	_aHydrazones _xtherapeutic use
650	0	4	_aLeukemia, Myeloid, Acute _xdrug therapy
650	0	4	_aNeuroblastoma _xdrug therapy
650	0	4	_aPyridazines _xtherapeutic use
650	0	4	_aSeverity of Illness Index
650	0	4	_aSimendan
700	1		_aDipchand, Anne I
700	1		_aMohseni-Bod, Hadi
773	0		_tCardiology in the young _gvol. 24 _gno. 3 _gp. 524-7
856	4	0	_uhttps://doi.org/10.1017/S1047951113000565 _zAvailable from publisher's website
999			_c22737070 _d22737070